Case Studies

Biostatistics Services Case Studies

IDMC support for a study assessing a novel therapeutic for severe COVID-19.

Functional service provision to support a vaccine clinical trial.

Biostatistics Services

Generating a statistical evidence package to support orphan drug designation.

Biostatistics Services

Biostatistics support for an early phase oncology clinical trial.

Biostatistics Services Case Studies

IDMC support for a study assessing a novel therapeutic for severe COVID-19.

Functional service provision to support a vaccine clinical trial.

Biostatistics Services

Generating a statistical evidence package to support orphan drug designation.

Biostatistics Services

Biostatistics support for an early phase oncology clinical trial.

Biostatistics Services Case Studies

IDMC support for a study assessing a novel therapeutic for severe COVID-19.

Functional service provision to support a vaccine clinical trial.

Biostatistics Services

Generating a statistical evidence package to support orphan drug designation.

Biostatistics Services

Biostatistics support for an early phase oncology clinical trial.

Statistical Consulting Services Case Studies

Quantitative evidence from simulation supports RSV programme investment

Generating synthetic control arms to repurpose treatments for patients with severe COVID-19.

Establishing biomarkers of treatment efficacy in liver disease.

Creating Go/No Go decision-making criteria for early-stage studies.

Building and validating a composite biomarker model to predict emphysema progression.

Simulating patient level outcome data to inform clinical trial design based on real-world, clinical trial and literature data.

Effective precision medicine strategies with KerusCloud.

Identifying the best overall strategy for study designs and drug development pathways.

Bayesian Extrapolation

Bayesian Extrapolation to Evaluate Efficacy in Pediatric Subjects using Adult Data.

Enabling early approval

Enabling early approval with a smarter approach to generating robust clinical evidence.

Statistical Consulting Services Case Studies

Quantitative evidence from simulation supports RSV programme investment

Generating synthetic control arms to repurpose treatments for patients with severe COVID-19.

Establishing biomarkers of treatment efficacy in liver disease.

Creating Go/No Go decision-making criteria for early-stage studies.

Building and validating a composite biomarker model to predict emphysema progression.

Simulating patient level outcome data to inform clinical trial design based on real-world, clinical trial and literature data.

Effective precision medicine strategies with KerusCloud.

Identifying the best overall strategy for study designs and drug development pathways.

Bayesian Extrapolation

Bayesian Extrapolation to Evaluate Efficacy in Pediatric Subjects using Adult Data.

Enabling early approval

Enabling early approval with a smarter approach to generating robust clinical evidence.

Statistical Consulting Services Case Studies

Quantitative evidence from simulation supports RSV programme investment

Generating synthetic control arms to repurpose treatments for patients with severe COVID-19.

Establishing biomarkers of treatment efficacy in liver disease.

Creating Go/No Go decision-making criteria for early-stage studies.

Building and validating a composite biomarker model to predict emphysema progression.

Simulating patient level outcome data to inform clinical trial design based on real-world, clinical trial and literature data.

Effective precision medicine strategies with KerusCloud.

Identifying the best overall strategy for study designs and drug development pathways.

Bayesian Extrapolation

Bayesian Extrapolation to Evaluate Efficacy in Pediatric Subjects using Adult Data.

Enabling early approval

Enabling early approval with a smarter approach to generating robust clinical evidence.

Data Science Services Case Studies

Identifying disease areas and endpoints that best demonstrate treatment efficacy.

Constructing a synthetic control arm for a study with a small population.

Data Science Services Case Studies

Identifying disease areas and endpoints that best demonstrate treatment efficacy.

Constructing a synthetic control arm for a study with a small population.

Data Science Services Case Studies

Identifying disease areas and endpoints that best demonstrate treatment efficacy.

Constructing a synthetic control arm for a study with a small population.

KerusCloud Use Case Examples

Identifying an adaptive trial design to maximise success with a smaller sample size.

Adapting to new information to identify a hidden risk, the impact of correlations.

KerusCloud Use Case Examples

Identifying an adaptive trial design to maximise success with a smaller sample size.

Adapting to new information to identify a hidden risk, the impact of correlations.

KerusCloud Use Case Examples

Identifying an adaptive trial design to maximise success with a smaller sample size.

Adapting to new information to identify a hidden risk, the impact of correlations.

    Learn how KerusCloud helped provide evidence which was used to support raising US$30 million in a subsequent financing round.

    X